Picture of Ajanta Pharma logo

AJANTPHARM — Ajanta Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

India's Ajanta Pharma gains after Jefferies starts coverage with 'buy'

** Shares of Ajanta Pharma AJPH.NS rise 2.4% to 2,626.30 rupees

** Jefferies starts coverage on AJPH with 'buy' and price target of 2,850 rupees

** Brokerage expects AJPH to further improve its market positioning and achieve mid-teens revenue growth for branded generics segment

** Co expected to achieve 200 bps margin expansion to 29.5% on rising contribution from branded generic markets - Jefferies

** Brokerage sees limited impact from potential US reciprocal tariffs for AJPH margins as US margins are much lower than company avg

** Analysts, on average, rate AJPH at "buy", median PT is 2,990 rupees - data compiled by LSEG

** AJPH down ~10% in 2025 after gaining 40.7% in 2024

 (Reporting by Vijay Malkar)

 ((VijayDattaram.Malkar@thomsonreuters.com;))

Recent news on Ajanta Pharma

See all news